Korean J Pain.  2022 Jul;35(3):271-279. 10.3344/kjp.2022.35.3.271.

Synergistic interaction between acetaminophen and L-carnosine improved neuropathic pain via NF-κB pathway and antioxidant properties in chronic constriction injury model

Affiliations
  • 1Neuroscience and Inflammation Unit, Department of Physiology, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Kwara State, Nigeria
  • 2Neuroscience and Inflammation Unit, Department of Physiology, Adeleke University, Ede, Osun State, Nigeria
  • 3Department of Nursing, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel

Abstract

Background
Inflammation is known to underlie the pathogenesis in neuropathic pain. This study investigated the anti-inflammatory and neuroprotective mechanisms involved in antinociceptive effects of co-administration of acetaminophen and L-carnosine in chronic constriction injury (CCI)-induced peripheral neuropathy in male Wistar rats.
Methods
Fifty-six male Wistar rats were randomly divided into seven experimental groups (n = 8) treated with normal saline/acetaminophen/acetaminophen + L-carnosine. CCI was used to induce neuropathic pain in rats. Hyperalgesia and allodynia were assessed using hotplate and von Frey tests, respectively. Investigation of spinal proinflammatory cytokines and antioxidant system were carried out after twenty-one days of treatment.
Results
The results showed that the co-administration of acetaminophen and Lcarnosine significantly (P < 0.001) increased the paw withdrawal threshold to thermal and mechanical stimuli in ligated rats compared to the ligated naïve group. There was a significant (P < 0.001) decrease in the levels of nuclear factor kappa light chain enhancer B cell inhibitor, calcium ion, interleukin-1-beta, and tumour necrotic factor-alpha in the spinal cord of the group coadministered with acetaminophen and L-carnosine compared to the ligated control group. Co-administration with acetaminophen and L-carnosine increased the antioxidant enzymatic activities and reduced the lipid peroxidation in the spinal cord.
Conclusions
Co-administration of acetaminophen and L-carnosine has anti-inflammatory effects as a mechanism that mediate its antinociceptive effects in CCIinduced peripheral neuropathy in Wistar rat.

Keyword

Acetaminophen; Anti-Inflammatory Agents; Antioxidants; Carnosine; Cytokines; Hyperalgesia; Lipid Peroxidation; Neuralgia; NF-kappa B; Spinal Cord

Figure

  • Fig. 1 Acetaminophen significantly increased paw withdrawal latency on the hotplate test. Data were represented as mean ± standard error of the mean (n = 8). aP < 0.05 vs. ligated control, bP < 0.05 vs. sham control.

  • Fig. 2 Acetaminophen + L-carnosine significantly increased paw withdrawal threshold to von Frey filament. Data were represented as mean ± standard error of the mean (n = 8). aP < 0.05 vs. ligated control, bP < 0.05 vs. sham control.

  • Fig. 3 Acetaminophen + L-carnosine mitigated proinflammatory mediators. Acetaminophen and L-carnosine significantly reduced proinflammatory mediators in the spinal lumbar neurons. (A) Acetaminophen + L-carnosine significantly inhibit tumour necrotic factor-alpha (TNF-α) concentration. (B) Acetaminophen + L-carnosine significantly reduced interleukin-1-beta (IL-1β) concentration. (C) Acetaminophen + L-carnosine significantly attenuated nuclear factor kappa light chain enhancer B cell inhibitor (NF-κB) concentration. (D) Acetaminophen + L-carnosine significantly inhibit calcium (Ca2+) ion concentration. Data were represented as mean ± standard error of the mean (n = 8). aP < 0.05 vs. ligated control, bP < 0.05 vs. sham control.

  • Fig. 4 Acetaminophen + L-carnosine improved neuroprotection of the neurons against oxidative stress. Combined treatment with acetaminophen and L-carnosine significantly increased antioxidant enzyme activities and reduced lipid peroxidation. (A) Acetaminophen + L-carnosine significantly reduced malondialdehyde (MDA) concentration. (B) Acetaminophen + L-carnosine significantly increased superoxide dismutase (SOD) activities. (C) Acetaminophen + L-carnosine significantly increased glutathione (GSH) concentration. Data were represented as mean ± standard error of the mean (n = 8). aP < 0.05 vs. ligated control, bP < 0.05 vs. sham control.

  • Fig. 5 Micrograph showing haematoxyline and eosin stained longitudinal section of the left sciatic nerve. Sciatic nerve ligation induces lost of myelinated (single broken yellow arrow) and unmyelinated (single broken black arrow), shrinkage and lost of nuclei of Schwann cell (single broken red arrow), vacuolarization (black arrow head). Acetaminophen + L-carnosine improved cytoarchitecture of the sciatic nerve by preserving the myelinated (double-broken yellow arrow) and unmyelinated (double-broken black arrow) fibres, nuclei of Schwann cell (red arrow head), regeneration of myelinated neuron (yellow arrow head), and reduces vacuolarization. Red arrow indicate normal Schwann cell, normal myelinated nerve fibre (yellow arrow), and normal unmyelinated nerve fibre (black arrow). (A) Unligated naïve group, (B) Sham group, (C) Ligated naïve group, (D) Post-treated acetaminophen group, (E) Pre-treated acetaminophen group, (F) Post-treated acetaminophen + L-carnosine group, (G) Pre-treated acetaminophen + L-carnosine group.


Reference

1. Murphy D, Lester D, Clay Smither F, Balakhanlou E. 2020; Peripheral neuropathic pain. NeuroRehabilitation. 47:265–83. DOI: 10.3233/NRE-208002. PMID: 32986619.
Article
2. Bravo L, Llorca-Torralba M, Suárez-Pereira I, Berrocoso E. 2020; Pain in neuropsychiatry: insights from animal models. Neurosci Biobehav Rev. 115:96–115. DOI: 10.1016/j.neubiorev.2020.04.029. PMID: 32437745.
Article
3. Finnerup NB, Kuner R, Jensen TS. 2021; Neuropathic pain: from mechanisms to treatment. Physiol Rev. 101:259–301. DOI: 10.1152/physrev.00045.2019. PMID: 32584191.
Article
4. Peng J, Gu N, Zhou L, Eyo UB, Murugan M, Gan WB, et al. 2016; Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun. 7:12029. DOI: 10.1038/ncomms12029. PMID: 27349690. PMCID: PMC4931235. PMID: 718c07a2fe284ea1b1b6c6e085269f46.
Article
5. Fonseca MM, Davoli-Ferreira M, Santa-Cecília F, Guimarães RM, Oliveira FFB, Kusuda R, et al. 2020; IL-27 counteracts neuropathic pain development through induction of IL-10. Front Immunol. 10:3059. DOI: 10.3389/fimmu.2019.03059. PMID: 32047492. PMCID: PMC6997342. PMID: 9d29671462ae4393ba0ae6f5d8f3cd14.
Article
6. O'Reilly ML, Tom VJ. 2020; Neuroimmune system as a driving force for plasticity following CNS injury. Front Cell Neurosci. 14:187. DOI: 10.3389/fncel.2020.00187. PMID: 32792908. PMCID: PMC7390932. PMID: 88a6f725a1144e30817ab4ac7eb2fddf.
7. Tang J, Bair M, Descalzi G. 2021; Reactive astrocytes: critical players in the development of chronic pain. Front Psychiatry. 12:682056. DOI: 10.3389/fpsyt.2021.682056. PMID: 34122194. PMCID: PMC8192827. PMID: 8bba54cfab8244f8b420e002cfecfbaa.
Article
8. Salvemini D, Little JW, Doyle T, Neumann WL. 2011; Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med. 51:951–66. DOI: 10.1016/j.freeradbiomed.2011.01.026. PMID: 21277369. PMCID: PMC3134634.
Article
9. Apfel CC, Turan A, Souza K, Pergolizzi J, Hornuss C. 2013; Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis. Pain. 154:677–89. DOI: 10.1016/j.pain.2012.12.025. PMID: 23433945.
Article
10. Roy S, Simalti AK. 2018; Comparison of antipyretic efficacy of intravenous (IV) acetaminophen versus oral (PO) acetaminophen in the management of fever in children. Indian J Pediatr. 85:1–4. DOI: 10.1007/s12098-017-2457-3. PMID: 28887752.
Article
11. Trexler ET, Smith-Ryan AE, Stout JR, Hoffman JR, Wilborn CD, Sale C, et al. 2015; International society of sports nutrition position stand: beta-alanine. J Int Soc Sports Nutr. 12:30. DOI: 10.1186/s12970-015-0090-y. PMID: 26175657. PMCID: PMC4501114.
Article
12. Baguet A, Koppo K, Pottier A, Derave W. 2010; Beta-alanine supplementation reduces acidosis but not oxygen uptake response during high-intensity cycling exercise. Eur J Appl Physiol. 108:495–503. DOI: 10.1007/s00421-009-1225-0. PMID: 19841932.
Article
13. Boldyrev AA, Aldini G, Derave W. 2013; Physiology and pathophysiology of carnosine. Physiol Rev. 93:1803–45. DOI: 10.1152/physrev.00039.2012. PMID: 24137022.
Article
14. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. 2020; The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. J Cereb Blood Flow Metab. 40:1769–77. DOI: 10.1177/0271678X20943823. PMID: 32663096. PMCID: PMC7430098.
Article
15. Bennett GJ, Xie YK. 1988; A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:87–107. DOI: 10.1016/0304-3959(88)90209-6. PMID: 2837713.
Article
16. Aydın AF, Küçükgergin C, Ozdemirler-Erata G, Koçak-Toker N, Uysal M. 2010; The effect of carnosine treatment on prooxidant-antioxidant balance in liver, heart and brain tissues of male aged rats. Biogerontology. 11:103–9. DOI: 10.1007/s10522-009-9232-4. PMID: 19430956.
Article
17. Im KS, Jung HJ, Kim JB, Lee JM, Park HJ, Joo CH, et al. 2012; The antinociceptive effect of acetaminophen in a rat model of neuropathic pain. Kaohsiung J Med Sci. 28:251–8. DOI: 10.1016/j.kjms.2011.11.003. PMID: 22531303.
Article
18. Bakare AO, Owoyele BV. 2020; Antinociceptive and neuroprotective effects of bromelain in chronic constriction injury-induced neuropathic pain in Wistar rats. Korean J Pain. 33:13–22. DOI: 10.3344/kjp.2020.33.1.13. PMID: 31888313. PMCID: PMC6944371.
Article
19. Misra HP, Fridovich I. 1972; The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247:3170–5. DOI: 10.1016/S0021-9258(19)45228-9. PMID: 4623845.
Article
20. Ellman GL. 1959; Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–7. DOI: 10.1016/0003-9861(59)90090-6. PMID: 13650640.
Article
21. Gutteridge JM, Wilkins S. 1982; Copper-dependent hydroxyl radical damage to ascorbic acid: formation of a thiobarbituric acid-reactive product. FEBS Lett. 137:327–30. DOI: 10.1016/0014-5793(82)80377-3. PMID: 6277694.
22. Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D. 2008; Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats. J Ethnopharmacol. 120:56–62. DOI: 10.1016/j.jep.2008.07.049. PMID: 18762236.
Article
23. Kim SH, Nam JS, Choi DK, Koh WW, Suh JH, Song JG, et al. 2011; Tumor necrosis factor-alpha and apoptosis following spinal nerve ligation injury in rats. Korean J Pain. 24:185–90. DOI: 10.3344/kjp.2011.24.4.185. PMID: 22220239. PMCID: PMC3248581.
Article
24. Shim DJ, Yang L, Reed JG, Noebels JL, Chiao PJ, Zheng H. 2011; Disruption of the NF-κB/IκBα autoinhibitory loop improves cognitive performance and promotes hyperexcitability of hippocampal neurons. Mol Neurodegener. 6:42. DOI: 10.1186/1750-1326-6-42. PMID: 21663635. PMCID: PMC3141554.
Article
25. Dresselhaus EC, Meffert MK. 2019; Cellular specificity of NF-κB function in the nervous system. Front Immunol. 10:1043. DOI: 10.3389/fimmu.2019.01043. PMID: 31143184. PMCID: PMC6520659.
Article
26. Bakare AO, Owoyele BV. 2021; Bromelain reduced pro-inflammatory mediators as a common pathway that mediate antinociceptive and anti-anxiety effects in sciatic nerve ligated Wistar rats. Sci Rep. 11:289. DOI: 10.1038/s41598-020-79421-9. PMID: 33432004. PMCID: PMC7801445. PMID: d37c0ad8795f4313b44249b638a506ae.
Article
27. Rajanandh MG, Kosey S, Prathiksha G. 2014; Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients - a randomized controlled study. Pharmacol Rep. 66:44–8. DOI: 10.1016/j.pharep.2013.08.003. PMID: 24905305.
Article
28. Zhou YQ, Liu DQ, Chen SP, Chen N, Sun J, Wang XM, et al. 2020; Nrf2 activation ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain. Acta Pharmacol Sin. 41:1041–8. DOI: 10.1038/s41401-020-0394-6. PMID: 32203087. PMCID: PMC7470811.
Article
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr